| First Author | Cicchini M | Year | 2017 |
| Journal | Cell Rep | Volume | 18 |
| Issue | 8 | Pages | 1958-1969 |
| PubMed ID | 28228261 | Mgi Jnum | J:254389 |
| Mgi Id | MGI:6103784 | Doi | 10.1016/j.celrep.2017.01.069 |
| Citation | Cicchini M, et al. (2017) Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression. Cell Rep 18(8):1958-1969 |
| abstractText | Expression of oncogenic Kras(G12D) initiates lung adenomas in a mitogen-activated protein kinase (MAPK) signal-dependent manner from only a subset of cell types in the adult mouse lung. Amplification of MAPK signaling is associated with progression to malignant adenocarcinomas, but whether this is a cause or a consequence of disease progression is not known. To better understand the effects of MAPK signaling downstream of Kras(G12D) expression, we capitalized on the ability of Braf inhibition to selectively amplify MAPK pathway signaling in Kras(G12D)-expressing epithelial cells. MAPK signal amplification indeed promoted the rapid progression of established adenomas to malignant adenocarcinomas. However, we observed, surprisingly, a greater number of overall tumor-initiating events after MAPK signal amplification, due to induced proliferation of cell types that are normally refractory to Kras(G12D)-induced transformation. Thus, MAPK signaling in the lung is thresholded not only during malignant progression but also at the moment of tumor initiation. |
